Bio-Techne Corp (STU:TE1)
€ 69.5 0 (0%) Market Cap: 11.07 Bil Enterprise Value: 11.27 Bil PE Ratio: 80.74 PB Ratio: 5.63 GF Score: 95/100

Bio-Techne Corp at Robert W Baird Global Healthcare Conference Transcript

Sep 04, 2019 / 02:15PM GMT
Release Date Price: €42.13 (-1.08%)
Catherine Walden Ramsey Schulte
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst

Everybody, I'm Catherine Schulte. I cover Life Sciences and Diagnostics here at Baird. We're very pleased to have Bio-Techne presenting here today representing the company. So if you have a question at any time, you can email [email protected]. And I will pass it along to Chuck. Chuck?

Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director

Great. All right, I'm on this, good. First slide, there's our new tagline, so Where Science Intersects Innovation. If you guys have ever worked on a tagline, it's harder than it sounds. I'd say dozens of hours of conflict within the team, but I like this one, finally. I think marketing finally nailed it. So -- and we're a lot about science, and we think we're a lot about innovation. And we've certainly been growing and there's a lot to talk about, so. Next slide. Guess I could do it. So we're -- we were up as high as $8 billion, it's been a tough market the last few weeks. But we're up to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot